The Scientist - Interview: Turning Tumors Against Themselves From the Inside.

White House Cancer Moonshot Fact Sheet: Earli named one of the key future technologies for cancer treatment.

S. Korea #1 Business Newspaper Maeil: Ordering Cancer Cells to "Self-Destruct"? U.S. Biotech Firm Unveils Breakthrough Gene Technology (in Korean language/translated).

Fast Company feature story: The fundamental change Earli may bring to patients: A cancer genius died from cancer. His startup is getting revenge.

Genetic Engineering & Biotechnology News: How Earli built a world-class team to solve one of the most difficult science problems: “Synthetic” Biomarkers Light Up Hidden Malignant Cancers.

Drug Discovery Trends: Earli's newest partnership. Earli and Accenture partner in quest to turn cancer against itself.

Newsweek Opinion: Why early detection misses the mark without Early Treatment:  One Glaring Problem in the U.S. Plan to Reduce Cancer Deaths.

CGT Live: Using DNA Nanoplasmids as a Diagnostic Tool in Cancer.

Tech Target: Using a synthetic targeting platform that forces cancer cells to express synthetic biomarkers, Earli Inc. is developing strategies for early cancer detection.

Entrepreneur: The Heartbreaking Loss of a Child to Cancer Brought These 3 Founders Together.

Pharmaceutical Technology: Accenture Invests in Earli's Cancer Detection Tech.

Sydney Morning Herald: Earli’s human trial: Australia’s ‘high quality’ clinical trials lure Silicon Valley cancer fighting company.

World Economic Forum selects Earli: 100 firms worldwide to join its Global Innovator community.

Fast Company: Earli the only early cancer detection firm in list of 2021 World Changing Ideas.

WIRED Feature: How Earli forces cancer to draw a “map” to itself:  A Proactive Way to Detect Cancer at Its Earliest Stages.

The Atlantic: Medical Revolution Too Late for the Man Who Started It.

Nikkei: Cancer treatment: control over early detection (in Japanese language).

Tough Tech Today: Co-founder Cyriac Roeding tells the story of Earli in a video podcast.

S. Korea: Medical Newspaper: A new frontier in cancer treatment: controlling cancer cells and making them self-destruct (in Korean Language)

German BusinessWeek (Wirtschaftswoche): tells the story and breakthrough potential of Earli (in German language).

Forbes: This Company Raised $40 Million To Make Tumors Reveal Themselves.

Business Wire: Earli raises $40M in Series A funding led by Khosla Ventures, with Perceptive Advisors, Casdin Capital, Andreessen Horowitz, Sands Capital, two years after its $19.5M Seed round led by Andreessen Horowitz’s Bio Fund.

Stat News: Sam Gambhir described how new ways to detect cancer early will help pave the way for precision health.